Hypertension (high blood pressure) Board decisions

The Board denied the Veteran's claim for a disability rating in excess of 70 percent for his service-connected post-traumatic stress disorder (PTSD) as the evidence did not support a higher rating.

The Board granted service connection for hypertension but denied it for pseudofolliculitis barbae.

The Board granted service connection for hypertension and chronic kidney disease, both based on the PACT Act. Bilateral hearing loss was denied.

The Board denied the veteran's claims for earlier effective dates and increased ratings, finding no evidence to support an earlier date of entitlement or a higher rating.

The Veteran has withdrawn the appeal for service connection for multiple conditions.

The Board granted service connection for an acquired psychiatric disorder, lumbar spine strain, hypertension, right ankle strain, left ankle strain, right hand tenosynovitis, left hand tenosynovitis, a right hip disability, and a left hip disability. The appeal was dismissed for sleep apnea, vertigo, a left knee disability, headaches, and coronary artery disease. Tinnitus and bilateral hearing loss were denied higher ratings.

The Board denied an earlier effective date for the grant of service connection for hypertension and a compensable disability rating, as there was no claim prior to August 10, 2022, when the PACT Act became effective.

The Board remands the issues of service connection for diabetes, hypertension, and prostate cancer to correct a duty to assist error related to notice of the Veteran's right to a hearing before the AOJ.

The Board restored the effective date of April 1, 2021, for the award of a 10 percent rating for hypertension and granted a higher rating of 20 percent from October 16, 2021.

The Board granted restoration of a 70 percent rating for major depressive disorder with inhalant use disorder and granted a total disability rating based on individual unemployability due to service-connected disabilities, while dismissing the appeal for recurrent high blood pressure as untimely appealed and denying service connection for vitamin B12 deficiency and PTSD.

The Board restored the 30 percent rating for tension headaches and denied a higher rating for hypertension, while remanding service connection for melanoma in-situ.

The Board denied service connection for bilateral hearing loss and a compensable rating for hypertension based on the evidence not showing current disabilities meeting VA criteria.

The Board remands the claims for service connection and initial rating due to a duty to assist error regarding notice of the right to a hearing.

The Board denied a compensable rating for hypertension and granted an effective date of September 28, 2018, for the grant of service connection.

The Board granted service connection for the Veteran's cause of death, finding that his service-connected PTSD contributed substantially to his hypertension, which was the primary cause of his death.

The Board denied compensation under 38 U.S.C. § 1151 for residuals of ablation of the posterior urethral valve surgery, other than urine retention, from January 4, 2005, to April 2010.

The Board denied service connection for a lumbar spine disorder and hypertension as there was no evidence of a current disability, in-service incurrence or aggravation of a disease or injury, and a nexus between the claimed in-service disease or injury and the present disease or injury.

The Board denied service connection for diabetes mellitus, diabetic peripheral neuropathy of both lower extremities, and hypertension. The Board also denied an initial compensable evaluation for a right upper arm burn scar and a right hand scar, as well as a 10 percent evaluation based upon multiple noncompensable service-connected disabilities.

The Board remands the claims for an initial rating in excess of 10 percent for a left knee disability, service connection for a neck disability, service connection for a right knee disability, and service connection for hypertension due to a pre-decisional duty to assist error.

The Board granted a 10 percent rating for the Veteran's hypertension, effective August 10, 2022.